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Abstract
Background:  Cognitive deficits are a hallmark feature of both Down Syndrome (DS) and
Alzheimer's Disease (AD). Extra copies of the genes on chromosome 21 may also play an important
role in the accelerated onset of AD in DS individuals. Growing evidence suggests an important
function for cholesterol in the pathogenesis of AD, particularly in APP metabolism and production
of Aβ peptides. The ATP-Binding Cassette-G1 (ABCG1) transporter is located on chromosome
21, and participates in the maintenance of tissue cholesterol homeostasis.
Results:  To assess the role of ABCG1 in DS-related cognition, we evaluated the cognitive
performance of mice selectively over-expressing the ABCG1 gene from its endogenous regulatory
signals. Both wild-type and ABCG1 transgenic mice performed equivalently on several behavioral
tests, including measures of anxiety, as well as on reference and working memory tasks. No deficits
in hippocampal CA1 synaptic plasticity as determined with electrophysiological studies were
apparent in mice over-expressing ABCG1.
Conclusion: These findings indicate that although ABCG1 may play a role in maintaining cellular
or tissue cholesterol homeostasis, it is unlikely that excess ABCG1 expression contributes to the
cognitive deficits in DS individuals.
Background
The central nervous system is the most sterol-rich organ in
the body, containing over 25% of total body cholesterol
in only 2% of total body weight [1]. Cholesterol cannot
cross the blood brain barrier; therefore, sterol homeosta-
sis in the brain is largely regulated independently from
that in peripheral tissues. Aberrant brain cholesterol
metabolism has been associated with compromised Aβ
metabolism, cognitive function, and synaptogenesis [2].
In addition, a link between brain cholesterol metabolism
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and learning and memory was recently observed with the
demonstration that mice deficient in 24-hydroxylase do
not show long-term potentiation (LTP) and are pro-
foundly impaired in spatial learning tasks [3]. Under-
standing how genes that regulate sterol homeostasis in the
brain affect cognitive and neuronal function may there-
fore lead to insights into several disorders of the central
nervous system.
ABCG1 is the founding member of the ABCG subclass of
the ATP-Binding-Cassette (ABC) transporter superfamily
[4]. Like several other members of the ABCG family,
ABCG1 functions in the regulation of sterol homeostasis
and high density lipoprotein (HDL) metabolism. ABCG1
is widely expressed in a variety of tissues, with the highest
levels of expression observed in macrophage-rich tissues
such as the spleen, lungs, and thymus; correspondingly,
the majority of studies concerning ABCG1 function
focused on the peripheral tissues. There are, however, sev-
eral lines of evidence supporting the idea that ABCG1 may
have an important role in the CNS, particularly concern-
ing neurodegenerative disorders. ABCG1 is abundantly
expressed in the brain, including the hippocampal forma-
tion [5,6]. Additionally, ABCG1 mRNA and protein levels
are significantly increased in DS cortex, and over-expres-
sion of ABCG1 affects Aβ production in transfected cells
[7]. Interestingly, selective over-expression of ABCG1 in
vivo did not affect Aβ or amyloid levels in the PDAPP
mouse model of AD (Burgess et al., 2008), suggesting that
over-expression of ABCG1 is unlikely to contribute to the
early onset of AD in the DS population. As ABCG1 does
alter cholesterol homeostasis in the brain (Burgess et al.,
2008), it therefore remains possible that excess ABCG1
may influence neuronal physiology and contribute to the
cognitive deficits in DS individuals. The purpose of the
present study was to investigate the role of ABCG1 on cog-




All procedures were approved by the University of British
Columbia Animal Care Committee and are in accordance
with the Canada Council on Animal Care. ABCG1 bacte-
rial artificial chromosome (BAC) transgenic mice were
generated as previously described [6]. All animals were
group housed in standard cages in a colony maintained at
21°C. Animals were maintained on a 12-hour light/dark
cycle with access to food and water ad libitum.
ABCG1 Protein Expression Assay
To investigate protein expression of ABCG1 in adult brain,
mice were anesthetized by intraperitoneal administration
of 600 mg/kg Avertin (Sigma-Aldrich) or intramuscular
administration of a 20 mg/kg xylazine (Bayer) and 150
mg/kg ketamine (Bimeda-MTC) mixture, then perfused
for 7 min with phosphate buffered saline (PBS) contain-
ing 2500 U/L Heparin. Brains were collected and dissected
into cortex, hippocampus, and cerebellum, and snap fro-
zen at -80°C until analysis. ABCG1 protein expression
was detected in a crude total membranes preparation as
described [8]. Briefly, tissues were homogenized in 5 vol-
umes of lysis buffer (50 mM mannitol, 2 mM EDTA, 50
mM Tris HCl pH 7.6, and Complete protease inhibitor
(Roche)), and centrifuged at 500 × g to pellet nuclei and
debris. Between 400–450 μl of supernatant was layered
onto 600 μl of fractionation buffer (300 mM mannitol, 2
mM EDTA, 50 mM Tris HCl pH 7.6) and centrifuged at
100,000 × g for 45 min to pellet total membranes. Mem-
branes were resuspended in 150–200 μl of lysis buffer.
SDS was added to a final concentration of 1% prior to
Tris-glycine SDS-PAGE and immunoblotted with antibod-
ies against ABCG1 (Novus) and Na/K-ATPase (Novus) as
an internal loading control.
Behavioural Analysis
Behavioural analysis cohorts included a total of 22 female
mice, with 11 ABCG1 BAC Tg mice and 11 wild-type lit-
termate controls. Phenotypic assessment of ABCG1 BAC
Tg mice was carried out using the SHIRPA protocol [9] to
screen for any differences in baseline phenotype, as these
could markedly affect performance on cognitive tests.
Locomotor activity, exploratory behaviour and general
anxiety were analyzed using the open field test. A circular
arena with a diameter of 90 cm was set up directly under-
neath an overhead digital camera (Logitech QuickCam
Pro 5000) in a brightly lit room in an undisturbed, quiet
location. A room divider shielded the experimenter and
computer from the animal's view for the duration of the
task. Animals were brought into the testing room, and
given 5–10 minutes to adjust to the room's environment
in their home cages. Each mouse was placed in the arena
individually, and allowed to freely explore for 5 minutes,
while its activities were tracked and recorded using ANY-
maze™ (Stoelting Co.). Upon completing the task, the
mouse was removed from the arena by the experimenter
and returned to the home cage. The number of defeca-
tions in the arena was recorded for each mouse, and the
arena was cleaned with a mild soap following each test to
avoid transfer of olfactory cues between animals. Distance
traveled, average speed and path length serve as measures
of locomotor activity and exploratory behaviour. Anxiety
was assessed through measurement of time spent around
the edges of the arena relative to the time spent in the cen-
tre, and also by freezing and defecation.
Emotionality was specifically measured using the elevated
plus maze: an elevated maze with 2 open arms and 2
enclosed arms, set up in a room in an undisturbed, quietLipids in Health and Disease 2009, 8:5 http://www.lipidworld.com/content/8/1/5
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location. The experimenter and computer were behind a
room divider, hidden from the animal's view for the dura-
tion of the task. Animals were given 5–10 minutes in their
home cages to adjust to the testing room. Each mouse was
initially placed in the centre of the maze, and allowed 5
minutes of free exploration. The animal's activities were
tracked and recorded by an overhead camera (Logitech
QuickCam Pro 5000) and ANY-maze™. Upon completion
of the task, the mouse was returned to its home cage and
number of defecations was recorded before the maze was
cleaned with a mild soap prior to the next trial.
Assessment of Learning and Memory
Hippocampal-dependent learning and memory was
assessed using several variations of the Morris Water Maze
task. The water maze consisted of a circular white pool
(100 cm diameter, 54 cm height) filled with water to a
height of 36 cm. The water was rendered opaque using
white, non-toxic tempera paint. A circular platform (14
cm diameter, 35 cm height) was submerged in the pool
(about 1 cm below the surface), providing a ledge upon
which the mice could step to escape from the water. For
each trial, a mouse was released into the pool at one of
three release positions and allowed to search for the plat-
form. Each trial lasted a maximum of 60 seconds, after
which the mouse was manually guided to the platform
and allowed to remain on the platform for another 10 sec-
onds. All trials were tracked using an overhead digital
camera (Logitech QuickCam Pro 5000) and ANY-maze™
computer software.
The visible platform task was used to screen for any visual
deficits, as well as motor problems (such as inability to
swim) that may hinder an animal's ability to complete
water maze training trials. The platform was located about
2 cm above the surface of the water, and a visually con-
spicuous marker, such as a small coloured flag, was
attached to the top of the platform. The platform location
was changed for each of the 4 trials. Mice were released
into the pool and allowed 60 seconds to locate the plat-
form, while being tracked and recorded by ANY-maze™.
The experimenter noted any apparent deficits in vision or
motor behaviors.
The reference memory task was used to assess learning
and long-term memory for a fixed platform location. Dis-
tinct geometric shapes were attached to the walls of the
pool on three sides, and the experimenter and computer
system were hidden behind a dividing wall throughout
the experiment to avoid influence of extraneous cues.
Mice were trained for 4 trials per day, for a total of 5 days.
Twenty-four hours after the last training session, a probe
trial was administered, in which the platform was
removed from the pool and the mouse was allowed to
swim freely for the full 60 seconds. Time spent in the
quadrant of the pool that had previously contained the
platform was measured as an indication of memory reten-
tion.
Electrophysiology
For in vitro electrophysiology, aged animals were anesthe-
tized with isofluroane and decapitated. The brain was
removed and immersed in ice-cold sucrose artificial cere-
brospinal fluid (sACSF; pH7.2) containing (in mM):
110.00 sucrose, 60.00 NaCl, 3.00 KCl, 1.25 NaH2PO4,
28.00 NaHCO3, 0.50 CaCl2, 7.00 MgCl2, 5.00 dextrose
and 0.60 ascorbate, oxygenated with 95%O2/5%CO2.
Transverse hippocampal slices (350 μm) were generated
using a Vibratome Sectioning System 1500 (Ted Pella,
Redding, CA). Slices were gently transferred to an incuba-
tion chamber filled with oxygenated normal artificial cer-
ebrospinal fluid (ACSF; pH 7.2) containing (in mM):
125.0 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25.0 NaHCO3, 2
CaCl2, 1.3 MgCl2, and 10 dextrose, and maintained at
30°C for a minimum of 1 hour post-dissection. Slices
were then transferred to a recording chamber superfused
at a rate of 2 ml/min with 30°C, oxygenated ACSF. A
recording electrode (0.7–1.5 MΩ) filled with ACSF was
placed under visual guidance into the striatum radiatum
of the hippocampal CA1 region using an Olympus
BX51W1 microscope. Field excitatory postsynaptic poten-
tials (fEPSPs) were evoked using monophasic negative
current pulses (120 μs, 10–80 μA) supplied to the CA1
Schaeffer Collaterals via a concentric bipolar stimulating
electrode (FHC, Bowdoin, ME) connected to a digital
stimulus isolation unit (Getting Instruments, San Diego,
CA). Responses were acquired at 100 Hz using a Multi-
Clamp 700B amplifier (Molecular Devices, Sunnyvale,
CA) and collected on a computer for offline analysis. For
each slice, stimulus intensity was adjusted to yield 50–
55% of the maximal response. Prior to baseline measure-
ments, a paired-pulse protocol (50 ms inter-stimulus
interval) was employed. Baseline measurements were col-
lected using individual fEPSPs evoked every 15 seconds. A
steady baseline of 15 minutes was required for all
responses. Following baseline acquisition, a conditioning
protocol was applied: high frequency stimulation (HFS:
four bursts of 50 pulses at 100 Hz, 30 s between bursts) to
induce long-term potentiation. Immediately after the con-
ditioning protocol, baseline measurements were acquired
for a minimum of 1 hour. Following the hour of post
acquisition, a second paired-pulse protocol (50 ms inter-
stimulus interval) was conducted. Computed results were
processed for statistical analysis using Clampfit (Molecu-
lar Devices, Sunnyvale, CA), Excel 2007 (Microsoft) and
Statistica 7.0 (Statsoft). For all studies, data was presented
as means ± standard error of the mean (S.E.M.) and com-
pared using unpaired t-tests. Differences were considered
significant when P < 0.05.Lipids in Health and Disease 2009, 8:5 http://www.lipidworld.com/content/8/1/5
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Results
ABCG1 Expression in Brains of Transgenic Mice
As previously reported [6], over-expression of ABCG1 was
observed in the brains of ABCG1 transgenic mice that
were generated using a BAC insertion of the full human
ABCG1 gene (ABCG1 BAC Tg mice), with protein levels
between 3–8 fold higher than that observed in wild-type
littermate control animals (Figure 1A). The level of over-
expression varied with brain region, with greater over-
expression in the cortex and hippocampus as compared to
the cerebellum. This verified that our transgene does in
fact significantly increase ABCG1 protein levels in the
brain over endogenous levels.
Baseline Behavioural Analysis using SHIRPA
A cohort of 22 female mice (n = 11 ABCG1 BAC Tg, n = 11
wild-type; approximately 10 months of age) were assessed
using the categories described by the SHIRPA protocol [9]
to test whether over-expression of ABCG1 resulted in any
gross phenotypic abnormalities. Observations made
using the primary screen of the SHIRPA protocol showed
that animals expressing the ABCG1 BAC transgene had a
similar baseline phenotype to wild-type littermates (Fig-
ure 1B). ABCG1 BAC Tg mice did not display any abnor-
malities in physiological measures such as heart rate,
body tone and grip strength or in behavioural measures
such as irritability, aggression and exploratory activity.
Anxiety and General Locomotor Activity
ABCG1 BAC Tg mice (n = 11) and wild-type littermates (n
= 11; approximately 12 months of age) were next evalu-
ated for anxiety level and general locomotor activity, as
both factors can interfere with learning tasks and therefore
can drastically affect performance during cognitive assess-
ment. The single-trial Open Field Test revealed no differ-
ence between groups in time spent in different locations
in the arena. Both ABCG1 BAC Tg and wild-type mice
spent the majority of their time exploring the edges of the
open arena, and generally avoided the brightly lit centre of
the arena. No differences were observed when mice were
also analyzed for average speed in the arena, distance trav-
elled and time spent immobile or frozen in the arena (Fig-
ure 2), indicating that ABCG1 BAC Tg mice have normal
exploratory and locomotor behaviour and do not show
increased anxiety levels compared to wild-type animals.
The Elevated Plus Maze, a behavioural task specifically
designed to evaluate anxiety, was administered to verify
that anxiety levels are not altered in ABCG1 BAC Tg mice.
Wild-type and ABCG1 BAC Tg mice spent comparable
amounts of time in the different locations within the
maze, with both groups displaying preference for the
closed arms of the maze (Figure 2). There were no differ-
ences between groups in average speed or distance
traveled in the maze. Time spent immobile, an indicator
of anxiety, was also similar for both groups.
Learning and Memory
Mice expressing the ABCG1 BAC transgene were next eval-
uated against wild-type littermates on the Morris Water
Maze spatial reference memory task. The task consisted of
a 5-day acquisition phase in which mice were given 4 tri-
als per day and a maximum time of 60 seconds per trial to
locate a platform fixed in the North quadrant. Twenty-
four hours later, a probe trial was administered to test
recall of the platform location. ABCG1 BAC Tg mice dis-
played nearly identical average escape latency, or time to
locate the platform, over each day of acquisition as com-
pared to wild-type animals, and the learning curve was
very similar (Figure 3). These results indicate that ABCG1
over-expression does not significantly affect learning dur-
ing the acquisition phase of this water maze task.
Repeated-measures ANOVA revealed a significant effect of
training day, (p < 0.0001), but not group (p = 0.67). Per-
formance on the single-trial probe test was also compara-
ble between groups, with both wild-type and ABCG1 BAC
Tg mice spending the greatest amount of time searching in
the probe quadrant (North), which previously contained
the platform during training days. Both groups displayed
strong preference for the North quadrant, indicating that
both wild-type and ABCG1 BAC Tg mice were capable of
learning the task thoroughly, and were able to remember
visual cues associated with the platform location during
training trials. Additionally, the comparable performance
of ABCG1 BAC Tg and wild-type mice on both learning
during the acquisition phase or on memory recall in the
probe trial, also suggests that over-expression of ABCG1
alone does not negatively affect hippocampal neuron
function involved in the learning and memory required
for this task.
Excess ABCG1 does not alter synaptic plasticity
To test the capacity for synaptic plasticity in mice over-
expressing ABCG1, we monitored the induction of long-
term potentiation by applying high-frequency stimulation
(four bursts of 50 pulses at 100 Hz, 30 s between bursts)
to the Shaeffer collaterals of the CA1. Hippocampal slices
from both wild-type and ABCG1 BAC Tg animals demon-
strated robust long-term potentiation, suggesting intact
synaptic plasticity in transgenic animals (Figure 3C). In
addition to long-term potentiation, a paired-pulse proto-
col (50 inter-stimulus interval) was employed before and
after the high-frequency stimulation tetanus as a measure
of presynaptic properties [10]. Standard paired-pulse
facilitation was observed in both wild-type and ABCG1
BAC Tg animals (Figure 3D). Taken together, these results
indicate that the selective over-expression of ABCG1 does
not affect synaptic plasticity in the CA1.
Discussion
The present experiments investigated the effects of ABCG1
over-expression on both baseline behavioural phenotypeLipids in Health and Disease 2009, 8:5 http://www.lipidworld.com/content/8/1/5
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ABCG1 BAC Tg mice over-express the ABCG1 transporter in the cortex, hippocampus, and cerebellum, and show normal  behaviour Figure 1
ABCG1 BAC Tg mice over-express the ABCG1 transporter in the cortex, hippocampus, and cerebellum, and 
show normal behaviour. A) Crude membrane fractions were extracted from dissected brain regions and were subjected to 
Western blot. Blots were probed by polyclonal antibodies recognizing human and murine ABCG1 or Na/K-ATPase as a loading 
control. ABCG1 protein levels are increased 6-fold in cortex (Cor) and hippocampus (Hipp) and 3-fold in cerebellum (Cer) of 
ABCG1-BAC-Tg (Tg) mice relative to baseline levels in the equivalent region from wild-type (WT) controls. B) SHRPA primary 
screen on ABCG1 BAC Tg (ABCG1; n = 11) and wild-type (WT; n = 11) mice. Primary screen involves physiological profiling 
of each mouse, using a number of test categories and assigning a rating for each mouse in each category. All p values are non-
significant when compared to WT animals.Lipids in Health and Disease 2009, 8:5 http://www.lipidworld.com/content/8/1/5
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ABCG1 over-expression does not alter anxiety or general locomotor activity Figure 2
ABCG1 over-expression does not alter anxiety or general locomotor activity. ABCG1 BAC Tg (Tg; n = 11) and 
wild-type mice (WT; n = 11) were assessed for differences in anxiety or locomotor activity using the Open Field Test (A, C, E, 
G) and the Elevated Plus Maze (B, D, F, H). Data from each test were analyzed to include measures of time spent in maze loca-
tions (A, B), mean speed (C, D) and distance (E, F) and time spent immobile (G, H) in the maze. All p values are non-significant.Lipids in Health and Disease 2009, 8:5 http://www.lipidworld.com/content/8/1/5
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and cognition. ABCG1 BAC Tg mice were indistinguisha-
ble from wild-type animals when assessed using the
SHIRPA protocol, indicating that over-expression of
ABCG1 does not result in any gross metabolic distur-
bances that could affect observable behavioural or physi-
ological measures. Cognitive measures were also
demonstrated to be unaffected in transgenic animals. The
performance of ABCG1 BAC Tg mice on tasks measuring
anxiety, general locomotor activity and spatial learning
and memory were all comparable to those of wild-type
animals. Additionally, our results show that stimulation
of Schaeffer axon collaterals elicits comparable long-term
potentiation in both ABCG1 BAC Tg and wild-type ani-
mals. No significant difference in paired-pulse facilitation
was observed between ABCG1 BAC Tg mice and wild-type
littermates both prior to, and after tetanus stimulation,
ABCG1 over-expression does not impact spatial reference memory or synaptic plasticity Figure 3
ABCG1 over-expression does not impact spatial reference memory or synaptic plasticity. The Morris Water 
Maze was employed to assess spatial reference memory in wild-type (WT; n = 11) and ABCG1 BAC Tg (Tg; n = 11) animals. 
(A) Latency to platform. Each point represents an average of 4 daily trials during the training period. No significant difference 
was observed between the groups in the time taken to find the hidden platform. (B) Probe trial results from a single-trial test. 
Both control and ABCG1 over-expressing groups showed similar preference for the North (N) quadrant, which contained the 
platform on training trials. All p values are non-significant. (C) In vitro electrophysiology was performed on 350 μm thick hip-
pocampal slices derived from aged mice over-expressing ABCG1 (Tg) and wild-type (WT) littermates. High frequency stimula-
tion (HFS) was applied to the Schaeffer collaterals to induce LTP in the CA1 region. No significant difference was observed 
between wild-type and transgenic mice. (D) Two stimuli were applied to the Schaeffer collaterals, including paired-pulse facili-
tation in the CA1 region, before and after the HFS tetanus protocol. No significant differences were observed between wild-
type and transgenic mice, indicating that presynaptic release was unaffected by HFS in either mouse phenotype.Lipids in Health and Disease 2009, 8:5 http://www.lipidworld.com/content/8/1/5
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suggesting that the presynaptic properties of ABCG1-over-
expressing mice are intact. These data strongly suggest that
over-expression of ABCG1 alone is not sufficient to cause
changes in cognition, learning and memory or hippocam-
pal synaptic plasticity.
While ABCG1 over-expression does not elicit a change in
cognition, ABCG1 over-expression appears to alter the
brain at the cellular level. Although total brain cholesterol
levels are unaffected, over-expression of ABCG1 leads to
decreased levels of sterol precursors and 24S-hydroxycho-
lesterol in the brain, suggesting that ABCG1 suppresses
flux through the cholesterol biosynthetic pathway [6].
There are several possible explanations for the lack of
transgenic phenotype. It is possible that the changes
caused by over-expression of ABCG1 may be too subtle to
have globally obvious effects on cognition, producing
changes at the neuronal level that may be below the detec-
tion threshold of the behavioural and cognitive tests used
in our experiments. Another possible explanation for the
lack of transgenic phenotype is the existence of a compen-
satory pathway that acts to balance out the effects of
ABCG1 over-expression and maintain normal cognitive
functions in the brain. The ABCG4 transporter could
potentially act in this manner, as it is highly homologous
to ABCG1 and is co-expressed with ABCG1 in neurons
and astrocytes [11]. Moreover, ABCG4 has also been pro-
posed to be important in cholesterol homeostasis; both
ABCG1-deficient and ABCG4-deficient mice each exhibit
repression of SREBP-2 target genes involved in cholesterol
synthesis, suggesting that ABCG4 does function in regula-
tion of cholesterol levels. It is possible that the ABCG4
pathway compensates for imbalances caused by over-
expression of ABCG1, preventing major changes at the
level of cognition. Further studies will be required to
determine the exact functions of ABCG4 in brain choles-
terol homeostasis, and whether it is indeed part of a path-
way that could compensate for alterations in ABCG1
function.
Conclusion
In conclusion, no effect of ABCG1 over-expression was
seen in hippocampal synaptic plasticity and behavioural
parameters such as anxiety and general locomotor activ-
ity, or on learning and memory, suggesting that despite
changes in cholesterol flux in brain, it is unlikely that
over-expression of ABCG1 contributes to cognitive defi-
cits in the DS population.
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